Clinical trials recruiting in Lakewood, New Jersey
11
Recruiting trials
15
Conditions
Phase breakdown
Phase 2 7Phase 3 6
Conditions recruiting in Lakewood, New Jersey
Recruiting trials in Lakewood, New Jersey
- ATATcH Alternating Treatment Plans for Advanced Cancer
- Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
- Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
- Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
- Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
- Microbiotic Product to Promote Microbiome Health and Improve Chemotherapy Delivery
- Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
- Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer
- Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
- Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Common questions
How many clinical trials are recruiting in Lakewood, New Jersey?
11 recruiting trials have at least one study site in Lakewood, New Jersey.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.